CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
resectable or borderline resectable, previously untreated pancreatic adenocarcinoma. The primary objective of this study is to investigate t...
Phase 2
Orlando, Florida, United States and 3 other locations
(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...
Phase 3
Orlando, Florida, United States and 142 other locations
as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma...
Phase 2
Orlando, Florida, United States and 47 other locations
The goal of this clinical trial is to test an experimental treatment (immunotherapy) in pancreatic cancer patients. The main research objectives are:...
Phase 1
Orlando, Florida, United States and 14 other locations
after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...
Phase 3
Orlando, Florida, United States and 214 other locations
and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...
Phase 3
Orlando, Florida, United States and 176 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why was this study being done? SPOTLIGHT was a new clinical ...
Phase 3
Orlando, Florida, United States and 219 other locations
A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.
Phase 1
Lady Lake, Florida, United States and 15 other locations
This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced,...
Phase 1, Phase 2
Orlando, Florida, United States and 20 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prost...
Phase 1, Phase 2
Lake Mary, Florida, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal